Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome

This study has been completed.

Study NCT00097370 Information provided by GlaxoSmithKline

First Received: November 22, 2004 Last Updated: November 10, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2010
Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)